Policy Watch

  • Your Selections:

Refine Results

date

Type

Topics

Tags

Mixed Prospects for Vaccinating Children

In this Axios column, Drew Altman examines the data about what parents say they will do once their children ages 5-11 become eligible for a COVID-19 vaccine, and why it will take some time and a concerted outreach effort to match adult vaccination rates.

Perspective Read More

A Look at Who is Still Not Vaccinated Against COVID

In this Axios column, Drew Altman takes on the idea that communities of color are behind the problem of the unvaccinated in the U.S.

Perspective Read More

Why The California Recall Is Not a Harbinger of What Is to Come on COVID As a Campaign Issue

In this Axios column, Drew Altman examines the lessons for COVID-19 as a political issue from Governor Gavin Newsom’s resounding win in California’s recall election.

Perspective Read More

Parents Report More Negative Pandemic Effects on Kids Who Attend School Virtually vs. In-Person

In his latest Axios column, Drew Altman shows that parents feel that children have fared better during COVID attending school in-person than virtually in terms of academic performance and their mental health and wellbeing.

Perspective Read More

How Full FDA Approval Could Spur Vaccination

In this Axios column, Drew Altman says full FDA approval of COVID-19 vaccines can provide a big boost to vaccination efforts if treated as an opportunity for updated messaging from government officials at all levels and public health experts and new actions from employers.

Perspective Read More

The Health System Appears To Be Selling LGBT+ People Short

With much focus on equity in the nation’s health care system during the pandemic, Drew Altman’s Axios column brings attention to warning signs about health care provided to LGBT+ individuals.

Perspective Read More

The Sleeper Health Cost Policy

In this Axios column, Drew Altman unpacks President Biden’s recent executive order on promoting competition, exploring its significance for new efforts to control health costs by addressing consolidation in the health care industry.

Perspective Read More

Why Drug Price Negotiation Has Staying Power

In this Axios column, Drew Altman looks beyond Medicare to what’s at stake for employers and workers in the debate about the government negotiating drug prices.

Perspective Read More

Persistent Vaccine Myths

With news that the country has now vaccinated half of its population with at least one dose, This Drew Altman Axios column highlights the persistent COVID-19 vaccine myths that are believed by a substantial portion of the unvaccinated population and discusses the options to address vaccine misinformation.

Perspective Read More

We aren’t getting a national vaccine ‘passport.’ So let’s use the next best thing: CDC vaccination cards.

In this op-ed for The Washington Post, Drew Altman suggests a way out of the heated debate about a COVID-19 vaccination passport to help provide clarity about who is vaccinated and who still ought to wear masks in public spaces or the workplace by using something that already exists– CDC vaccination cards.

Perspective Read More

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.